M. Stojanović

Hyperfractionated radiation therapy for incompletely resected supratentorial low-grade glioma. A phase II study.

B. Jeremic, Y. Shibamoto, D. Grujičić, 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Disability and quality of life in Guillain-Barré syndrome – Longitudinal study

M. Stojanović, S. Peric, A. Kačar, 2020, Journal of Clinical Neuroscience.

A Prospective, Randomized, Phase III Study to Evaluate the Efficacy and Safety of Fibrin Sealant Grifols as an Adjunct to Hemostasis as Compared to Cellulose Sheets in Hepatic Surgery Resections

M. Stojanović, A. Vereczkei, M. Bjelović, 2018, Journal of Gastrointestinal Surgery.

Incidence and mortality rates of Guillain‐Barré syndrome in Serbia

M. Stojanović, I. Bozovic, G. Djordjević, 2020, Journal of the peripheral nervous system : JPNS.

Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study.

B. Jeremic, Y. Shibamoto, D. Grujičić, 1994, International journal of radiation oncology, biology, physics.

Alemtuzumab versus interferon beta 1a as first-line treatment for patients with relapsing-remitting multiple sclerosis: a randomised controlled phase 3 trial

Christian Confavreux, Gavin Giovannoni, Elizabeth Fisher, 2012, The Lancet.